Nilforushan Equisport Events Partner KindredBio Announces FDA Approval of New Equine Drug, Zimeta

Temecula, Calif. – Dec. 13, 2019 – The team at Nilforushan Equisport Events (NEE) is thrilled to congratulate 2019 Temecula Valley National Horse Show partner, KindredBio, on the approval of its new equine medicine, Zimeta. Thanks to the approval from the Food & Drug Administration (FDA), veterinarians will now be able to access and prescribe the first and only FDA-approved medication for the control of pyrexia (fever) in horses.
“We are so thrilled to hear of this new approval for our friends at KindredBio! They have been working and waiting for years regarding Zimeta, and we are so excited that it has finally been approved by the FDA. This drug will undoubtedly help the lives of many horses and is a perfect example of why we choose to align ourselves with this hard-working and reputable company that is as dedicated as we are to horse wellness and health,” commented Ali Nilforushan, Founder of Nilforushan Equisport Events.

The FDA approval of Zimeta is an exciting advancement for KindredBio, which is targeted to treat pyrexia, a fever associated with a number of underlying diseases and can result in significant negative outcomes, including dehydration, laminitis, muscle wasting, weight loss, and in some cases death. Among performance horses, fever can also lead to loss of training and competition days. Zimeta is a non-steroidal anti-inflammatory drug (NSAID). Dipyrone, the active ingredient in Zimeta, is a member of the pyrazolone class of NSAIDs and has a mechanism of action focused in the central nervous system where fever is regulated. Of the NSAIDs approved in the United States listed by the Fédération Equestre Internationale (FEI), dipyrone has the shortest established detection time in horses at 72 hours. This is the first-time dipyrone has been FDA-approved for veterinary use in the United States.

Mandy Porter, winner of the 2019 $40,000 KindredBio National Grand Prix at Temecula Valley National Premier
 
The team at NEE has been honored to partner with such a highly-regarded veterinary pharmaceutical company for the past two years. KindredBio focuses on improving the lives of horses, cats and dogs, and its mission is to bring animal companions the same kinds of safe and effective medicines that human family members enjoy by pursuing a development pipeline of novel drugs and biologics across many therapeutic classes.
KindredBio has been a top level supporter of the Temecula Valley National Horse Shows since the series’ inception in 2018. In 2019, the company served as the title sponsor of the $40,000 KindredBio National Grand Prix, which was won by Mandy Porter and Milano, during the first week of the 2019 series, in addition to hosting the highly-praised and fun “Fabulous Las Vegas” exhibitor welcome party. Dedicated to animal wellness, KindredBio also partnered with the Rancho Coastal Humane Society to organize the dog adoption event held at Galway Downs during the show. Thanks to their efforts, a number of furry friends found new homes!
Nilforushan Equisport Events is a horse show management company owned and operated by the husband-and-wife team of Ali and Francie Nilforushan. Their mission is to produce world-class events that will make California a top show jumping destination, as well as attract local residents to a number of entertainment experiences and world-class performances. Exhibitors can expect great sport, a first class VIP area and affordable showing options at every event thanks to the inventive style of the Nilforushan management team. Nilforushan Equisport Events looks forward to welcoming you to the 2020 Temecula Valley National Horse Show!
To learn more, follow KindredBio on FacebookInstagram or Twitter for updates on use guidance in competitive events.
For more information, please visit www.jump-nee.com or kindredbio.com.